SMARCB1 and rhabdoid tumor: Furthermore, recent next-generation sequencing studies demonstrate an overlap between SMARCB1-dependent promoter targets and tissue-specific lineage-determining genes that are downregulated in SMARCB1-deficient malignant rhabdoid tumours [62].